Table 4.
Anticoagulants |
NSAIDs |
|||||||
---|---|---|---|---|---|---|---|---|
PS method | Cov | RMSE | Mean | SD | Cov | RMSE | Mean | SD |
Unadjusted | 0.53 | 0.325 | −0.172 | 0.216 | 0.83 | 0.370 | −0.061 | 0.314 |
L1-Reg-All | 0.88 | 0.303 | 0.023 | 0.108 | 0.83 | 0.367 | −0.023 | 0.229 |
L1-Reg-OHDSI | 0.90 | 0.276 | −0.020 | 0.061 | 0.97 | 0.319 | −0.087 | 0.161 |
L1-Reg-HDPS | 0.86 | 0.275 | −0.026 | 0.089 | 0.83 | 0.387 | −0.115 | 0.228 |
bias-hdPSa | 0.86 | 0.258 | −0.037 | 0.065 | 0.88 | 0.347 | −0.065 | 0.135 |
bias-hdPS-Reg | 0.82 | 0.292 | −0.036 | 0.094 | 0.83 | 0.372 | −0.039 | 0.244 |
exp-hdPSb | 0.80 | 0.268 | −0.037 | 0.113 | N/A | N/A | N/A | N/A |
exp-hdPS-Reg | 0.80 | 0.284 | −0.037 | 0.096 | 0.86 | 0.434 | −0.154 | 0.320 |
Mean and SD are of the empirical null Gaussian distribution fit to the log hazard ratio estimates.
Cov, coverage of the null effect; RMSE, root mean squared error of log hazard ratio estimates from 0; SD, standard deviation.
bias-hdPS fails to converge on 12 of 29 outcomes in NSAIDs study.
exp-hdPS fails to converge on all 29 outcomes in NSAIDs study.